Nuclea Biotechnologies, Inc. — Form D

Nuclea Biotechnologies, Inc. of PITTSFIELD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-02-20. $1.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
William R HarmanDirectorNEW YORK, NY
Patrick J MuracaDirectorPittsfield, MA
Charles P StetsonDirectorPittsfield, MA
Richard R VietorDirectorSt. Louis, MO
Paula J EvansExecutive OfficerPittsfield, MA
Patrick J MuracaExecutive OfficerPittsfield, MA
Robert J PierceExecutive OfficerPittsfield, MA
Dennis K StoneDirectorHouston, TX
James W LewisDirectorJersey City, NJ
Richard W VietorDirectorPittsfield, MA
PAULA C EVANSExecutive OfficerPITTSFIELD, MA
Richard R. VietorDirectorPittsfield, MA
Patrick J. MuracaDirectorPittsfield, MA
Patrick J. MuracaExecutive OfficerPittsfield, MA
Robert J. PierceExecutive OfficerPittsfield, MA
Paula J. EvansExecutive OfficerPittsfield, MA
Charles P. StetsonDirectorPittsfield, MA
William R. HarmanDirectorPittsfield, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2012-08-08D$5.0M
2012-05-03D$555K
2012-04-11D$1.9M
2011-08-18D$3.0M
2010-12-17D$4.0M$425K
2010-12-08D
2010-11-01D/A$8.9M
2009-10-22D/A$3.4M
2009-06-24D$3.0M$1.0M

More